You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)與國藥物流合作 配送BioNTech mRNA新冠疫苗
阿思達克 12-11 10:41
復星醫藥(02196.HK)與國藥物流在上海舉行關於BioNTech mRNA新冠疫苗配送合作簽約儀式。由復星醫藥副總裁兼首席發展官李勝利與國藥物流總經理顧一民分別代表雙方公司簽約。

雙方將在全國範圍內開展疫苗產品儲存、配送以及供應鏈服務合作,此次簽約儀式是在國藥控股和復星醫藥簽署物流戰略合作的基礎上,進一步細化在冷鏈物流各個環節合作,雙方將發揮各自優勢,在疫苗的商業化、物流與供應鏈建設等方面加強聯動、協同發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account